TRX WOUND CARE LIMITED
Get an alert when TRX WOUND CARE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-10-27 (in 5mo)
Last made up 2025-10-13
Watchouts
Cash
—
Latest balance sheet
Net assets
-£22M
-0.8% vs 2023
Employees
0
Average over period
Profit before tax
-£171K
-135.4% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Name history
Renamed 1 time since incorporation
- TRX WOUND CARE LIMITED 2016-04-18 → present
- TRX WOUNDCARE LIMITED 2011-10-13 → 2016-04-18
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £1,096,000 | £1,696,000 | |
| Operating profit | £482,000 | -£171,000 | |
| Profit before tax | £483,000 | -£171,000 | |
| Net profit | £483,000 | -£171,000 | |
| Cash | — | — | |
| Total assets less current liabilities | -£21,818,000 | -£21,989,000 | |
| Net assets | -£21,818,000 | -£21,989,000 | |
| Equity | -£21,818,000 | -£21,989,000 | |
| Average employees | 0 | 0 | |
| Wages | £0 | £0 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 44.0% | -10.1% | |
| Net margin | 44.1% | -10.1% | |
| Return on capital employed | -2.2% | 0.8% | |
| Gearing (liabilities / total assets) | 467.7% | 399.0% | |
| Current ratio | 0.19x | 0.25x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors are satisfied that Tissue Regenix Group plc is capable of providing the necessary financial support and that the Company, therefore, has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the Directors of the Company continue to adopt the going concern basis in preparing the financial statements. The financial statements do not include any adjustments that would be required should the going concern basis of preparation no longer be appropriate.”
Group structure
- TRX WOUND CARE LIMITED · parent
- Tissue Regenix Wound Care Inc 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LUND, Kirsten Mary | Secretary | 2019-12-20 | — | — |
| LECOQUE, Jay Charles | Director | 2025-09-04 | Nov 1962 | American |
| LUND, Kirsten Mary | Director | 2025-10-16 | Nov 1983 | British |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DEVLIN, Paul John | Secretary | 2017-01-06 | 2018-01-31 |
| JONES, Gareth Hywel | Secretary | 2018-10-29 | 2019-12-20 |
| BARKER, Michael Denis | Director | 2019-08-28 | 2019-11-30 |
| COCKE, David Claiborne | Director | 2021-01-21 | 2025-07-31 |
| COULDWELL, Steven Ashley | Director | 2017-11-02 | 2019-07-31 |
| DEVLIN, Paul John | Director | 2017-01-06 | 2018-01-31 |
| GLENN, Jonathan Martin | Director | 2020-04-01 | 2025-09-05 |
| JEFFERSON, Ian David | Director | 2011-10-13 | 2016-11-21 |
| JONES, Gareth Hywel | Director | 2018-10-29 | 2020-11-24 |
| LEE, Daniel Ray | Director | 2020-11-16 | 2025-10-15 |
| ODELL, Antony Ruben | Director | 2011-10-13 | 2017-10-31 |
| SAMUEL, John Andrew Walter | Director | 2011-10-13 | 2020-03-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Tissue Regenix Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 67 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-05 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-11-03 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-11 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-11 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-20 | AA | accounts | Accounts with accounts type full | |
| 2025-08-04 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-03 | AA | accounts | Accounts with accounts type full | |
| 2023-10-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-28 | AA | accounts | Accounts with accounts type full | |
| 2023-01-31 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-01-31 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2022-10-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-20 | AA | accounts | Accounts with accounts type full | |
| 2021-11-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-25 | AA | accounts | Accounts with accounts type full | |
| 2021-02-03 | AP01 | officers | Appoint person director company with name date | |
| 2021-01-06 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+54.7%
£1,096,000 £1,696,000
-
Cash
—
Not reported
-
Net assets
-0.8%
-£21,818,000 -£21,989,000
-
Employees
—
Not reported
-
Operating profit
-135.5%
£482,000 -£171,000
-
Profit before tax
-135.4%
£483,000 -£171,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers